BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2000
View Archived Issues
Increased bone formation associated with Fra-1 and deltaFosB overexpression in transgenic mice
Read More
Antileukemia immune response identified
Read More
Arimidex does not compromise subsequent treatment of breast cancer with tamoxifen
Read More
Vion and Memorial Sloan-Kettering present preclinical TAPET data
Read More
Dura acquires distribution rights for Glaxo Wellcome dermatology product line
Read More
BioSante's CAP vaccine adjuvant completes phase I clinical trial
Read More
Gene therapy trial for blocked coronary arteries commenced by Genzyme Surgical Products
Read More
NeoRx's skeletal targeted radiotherapy progresses to phase III
Read More
Phase III trial of Actimmune begins for treatment of idiopathic pulmonary fibrosis
Read More
Intranasal apomorphine phase I results reported
Read More
DTI-015 phase I/II clinical trials begin enrollment for treatment of glioblastoma multiforme
Read More
Promising phase I data reported for Enzo Biochem gene medicine
Read More
Lasofoxifene's bone protective effects tested in multiple studies
Read More
Bone strength, density improved by LY-353381 in ovariectomized rats
Read More
MCC-565 prevents bone loss due to estrogen deficiency in monkeys
Read More
Oral alphavbeta3 antagonist L-806978 inhibits bone loss in vivo
Read More
Novel tricyclic compounds from Dr. Reddy useful for hyperglycemia, hyperlipidemia, etc.
Read More
Kinase inhibitors and their use in the treatment of cancer, psoriasis and osteoporosis
Read More
R&D at Darwin Discovery leads to new group of PDE4/TNF inhibitors
Read More
Series of microtubule-stabilizing epothilone derivatives jointly developed by BMS and GBF
Read More
BioChem Pharma reveals novel compounds for hepatitis C virus
Read More
Dihydroquinazoline antitumor agents with folate-independent mechanism described by CRC
Read More
Potent topoisomerase inhibitors related to camptothecin described in recent patent
Read More
IC-351 effective and safe as once-daily or on-demand therapy for ED
Read More
HEP-187, a new vitamin D analogue with a promising profile for metabolic bone diseases
Read More
Zeldox reaches market first in Sweden
Read More
ASBMR news: potent new cathepsin K inhibitor from SB prevents bone loss in ovariectomized rats
Read More